$6.27
▼ -0.1% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Here's Why Investors Should Stay Neutral on TDOC Stock for Now
3 Reasons to Sell TDOC and 1 Stock to Buy Instead
Overview
52-week range
$4.40
$9.89
34% of range
Avg surprise (last 2)
+36.0%
Avg reaction (last 1)
-1.9%
0% positive
Latest IV / EM
50%
EM ±2.1% · $7 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.21 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.36 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.28 | — | — | — | — | financials |
| Tue Jul 29, 2025 | Jun/2025 | $-0.19 | $-0.27 | +29.6% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.19 | $-0.33 | +42.4% | — | -1.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.19 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-4.92 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.49 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.35 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.40 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.42 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $614M | — | $626M | $632M | $629M | — | $641M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-37M | $-62M | — | $-52M | $-54M | $-121M | — | $-44M |
| Net income | $-39M | $-64M | — | $-50M | $-33M | $-93M | — | $-33M |
| EPS (diluted) | $-0.21 | $-0.36 | — | $-0.28 | $-0.19 | $-0.53 | — | $-0.19 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $774M | $751M | $781M | $726M | $680M | $1.19B | $1.30B | $1.24B |
| Inventory | $29M | $32M | $38M | $40M | $38M | $38M | $38M | $37M |
| Total current assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | $1.60B | $1.66B | $1.61B |
| Total assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B | $2.03B | $2.02B |
| Total equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B | $1.49B | $1.51B |